UNCONTROLLED COPY FOR TRAINING AND REFERENCE PURPOSES ONLY
BD
Frederick National Laboratory for
Cancer Research , Frederick , MD
Standard Operating Procedure
Biopharmaceutical Development Program
Title: Format, Content, and Identification of Standard Operating
Procedures
SOP Number:
21400
Supersedes: Revision
04
Revision Number:
05
Effective Date:
SEP
13 2018
Table of Contents
1.0 Purpose
2.0 Scope
3.0 Authority and Responsibility
4.0 Procedure
5.0 Definitions
6.0 References and Related Documents
7.0 Attachments
1.0 Purpose
This SOP defines the format, content, and identification system for Standard Operating
Procedures (SOPs) for each department in the Biopharmaceutical Development Program (BOP).
2.0 Scope
This procedure applies to Standard Operating Procedures written for the BOP. For origination,
modification, and control of SOPs, see
SOP 21418
Control and Request of
Documents/Records
and
SOP 21419- Origination, Modification, and Approval of
Documents.
This procedure is made available through federal funds from the National Cancer Institute, NIH, under contract
Originator/Date:
Approval/Date:
Approval/Date:
Page 2 of 12
FNLCR, BDP
SOP Number: 21400
Revision Number: 05
EffectiveDate: SEP 13 2018
UNCONTROLLED COPY FOR TRAINING AND REFERENCE PURPOSES ONLY
3.0 Authority and Responsibility
3.1 The Director, Regulatory Affairs, Biopharmaceutical Quality Assurance (BQA) has the
authority to define this procedure and is responsible for the implementation of this
procedure.
3.2 BQA or designee is responsible for:
3.2.1 Assigning SOP numbers and providing the SOP template (See Attachment 1) to
the originator when they request an SOP number for a new procedure.
3.2.2 Formatting the final SOP before it is routed for signature.
3.3 It is the responsibility of the Manager/Supervisor of each department to ensure that the
SOP is updated/revised on schedule.
3.4 The Director, Biopharmaceutical Quality Assurance, BQA is responsible for quality
oversight of this procedure.
4.0
Procedure
4.1 General SOP Format
4.1.1 Type the content of Standard Operating Procedures in Microsoft Word using Arial
Font, point size 11. Use left justification, and single-line spacing throughout the
SOP. Use complete sentences throughout the SOP, when appropriate.
4.1.2 Tables, Figures, and Diagrams may be incorporated within the body of text. Pages
may be oriented as portrait or landscape and reduced in size to accommodate
tables, figures, and/or diagrams.
4.1.3 BQA or designee will ensure existing SOPs are formatted using the current SOP
template (See Attachment 1) (as they are revised). The SOP/MEF Database auto-
converting “Create Draft” feature can be used to format the SOP before it is sent to
the requestor for revision.
4.1.4 Forms attached to SOPs follow a specific format. The header of the form consists
of the following:
FNLCR, BDP (first line)
Form No.: 21145-01 (Example)
SOP No.: 21145 (Example)
Revision 00:
If the form is a revision, the header will have the Revision Number: Revision
01, 02, etc.
4.1.4.1 Forms are inserted into the procedure as “.pdf” files when the SOP is
routed for signature. Forms may be oriented as portrait or landscape as
necessary.
This procedure is made available through federal funds from the National Cancer Institute, NIH, under contract .
Page 3 of 12
FNLCR, BDP
SOP Number: 21400
Revision Number: 05
EffectiveDate: SEP 13 2018
UNCONTROLLED COPY FOR TRAINING AND REFERENCE PURPOSES ONLY
4.1.4.2 Forms shall be uniquely identified with the SOP number immediately
followed by a hyphen and a two-digit number that reflects the form order
following the SOP. For example:
First SOP Form 21403-01;
Second SOP Form 21403-02;
Third SOP Form 21403-03.
4.1.4.3 Forms that are attached to other SOPs may be mentioned in the SOP but
may not be attached. For example, Form 21503-01 could be mentioned
in this SOP but cannot be attached to this SOP. Form references do not
include the revision number.
4.1.4.4 The form revision is the same as that of the SOP. For example, if the
SOP is Revision 01, then the Form is Revision 01.
4.1.4.5 The effective date of the form is the same effective date of the procedure
(SOP). BQA adds the effective date on the form when it is issued (i.e.,
Revision 00: APR 06 2018).
4.1.5 Attachments to SOPs are labeled using numbers; Attachment 1, 2, 3, et cetera.
4.1.6 Identifying SOPs in Word Processing
4.1.6.1 Use the SOP number as the electronic file name. Identify it as “DRAFT”
or “EFFECTIVE”, and the digits of the SOP number including the revision
number. Examples:
DRAFT SOP 12345, Rev. 00 (While the procedure is in review and
before the procedure is finalized.)
APPROVED SOP 12345. Rev. 00 (This is an automated step from the
database.) When you make the SOP Effective in the database (10
days from date of final signature) the system marks it approved.
EFFECTIVE SOP 12345, Rev. 00 (When the procedure is finalized
and posted on the effective date the database changes the file name
to “Effective”)
4.1.7 SOP Paper
4.1.7.1 The original, official master of the SOP is printed on white paper and
contains the handwritten, original signatures in black or blue ink.
4.1.7.2 Controlled copies are printed on blue paper and the control number is
printed on the footer of the controlled copy (that is assigned to an SOP
Manual). Example:
Control Number: 012345
This procedure is made available through federal funds from the National Cancer Institute, NIH, under contract
.
Page 4 of 12
FNLCR, BDP
SOP Number: 21400
Revision Number: 05
EffectiveDate: SEP 13 2018
UNCONTROLLED COPY FOR TRAINING AND REFERENCE PURPOSES ONLY
4.1.8 SOP Headers
4.1.8.1 The first line of page one of the SOP contains the name of the
organization and the words “Standard Operating Procedure”.
4.1.8.2 The second line in the first page header contains the title of the SOP.
(Use Font size 14).
4.1.8.3 The third line on the page one header contains the SOP Number and the
revision level. The revision number is 00 for new SOPs and 01 for the
first revision of the document, et cetera.
4.1.8.4 The fourth line in the header is the superseded revision number and the
effective date.
If the document is a new document, type N/A in the Supersedes section.
If the document is being revised, type in Revision 01 if it is replacing
Revision 00, or Revision 02 if it is replacing Revision 01, et cetera. If the
document number was changed, for example from 6002 to 21239, then
use 6002, and Revision 00 in the supersedes section.
4.1.8.5 Signatures are required on the first page only of the SOP.
The Originator/Date
BQA or designee ensures that the database
adds the originator’s name, and department (in bold, using pt 8 font);
the originator signs his/her name and date on this line to signify
approval.
At a minimum, two approval signatures/dates are required in addition
to the originator/author (the approver’s names and titles are typed
under each signature line). This includes the originator’s supervisor
and a Biopharmaceutical Quality Assurance (BQA) signature.
The originator's supervisor or manager, or system/area owner; or in
some instances, the Supervisor and Manager will sign in the approval
section. For SOPs that affect critical systems in the BDP, the
Program and Technical Director and the Director of BQA signatures
are required.
Biopharmaceutical Quality Assurance (BQA) reserves the right to
designate additional signatories.
SOPs that pertain to GxP (GMP, GLP, GCP, etc.) operations,
materials, systems, etc., require BQA review and signature.
4.1.9 General
4.1.9.1 When typing a note in the SOP, type it as follows in BOLD and
Underlined.
NOTE: Do not underline the colon or punctuation (unless the entire
sentence is underlined), except for the last punctuation mark.
The note is separate from the sentence, so it is easily read.
This procedure is made available through federal funds from the National Cancer Institute, NIH, under contract .
Page 5 of 12
FNLCR, BDP
SOP Number: 21400
Revision Number: 05
EffectiveDate: SEP 13 2018
UNCONTROLLED COPY FOR TRAINING AND REFERENCE PURPOSES ONLY
4.1.9.2 Use BOLD and 12-point font when typing the section titles in the SOP.
Example: Authority and Responsibility.
4.1.9.3 Put caution or warning statements in bold.
4.1.9.4 Use capital letters sparingly. Capital letters are harder to read.
4.1.9.5 Use the legal numbering system for SOPs. Use bullets to set off phrases.
4.1.9.6 A single section break must stay on the first page header, so the
second page header will be correct.
4.1.9.7 When a procedure is requested for a revision, a Revision Justification
Form 21419-02, must be included, see Section 6.0 of SOP 21419 -
Origination, Modification and Approval of Documents
4.1.9.8 Procedures that are referenced in the body of an SOP must include the
SOP number and the title each time they are referenced. Referenced
procedures are in BOLD Italics. Example:
SOP 21419 - Origination, Modification and Approval of
Documents
4.2 General SOP Contents
4.2.1 SOPs shall contain the following sections. Additional sections may be added as
necessary.
4.2.1.1 Title: Write a clear and concise title to allow the reader to identify the
contents of what is included within the SOP.
4.2.1.2 Purpose: State the purpose of the procedure being described. Write the
purpose in complete sentences.
4.2.1.3 Scope (Application): Give the intended personnel, situation, protocol,
location (wing/room number), project (if project specific), etc., to which the
procedure applies. Describe situations where the SOP would not apply.
Example: This SOP applies to BDP Production personnel in the
.
4.2.1.4 Overview (Optional): The purpose of the overview section is to make the
purpose, application, or use of the SOP easier to understand. It may
include background, historical, or other information. It could also include
information on the criticality of the SOP or certain steps within the SOP.
NOTE: When this section is included in the SOP it will be included in the
Table of Contents.
4.2.1.5 Authority and Responsibility: Briefly list by title and/or department the
individuals and their responsibilities for preparing, managing, using the
SOP, and updating the SOP.
This procedure is made available through federal funds from the National Cancer Institute, NIH, under contract .
Page 6 of 12
FNLCR, BDP
SOP Number: 21400
Revision Number: 05
EffectiveDate: SEP 13 2018
UNCONTROLLED COPY FOR TRAINING AND REFERENCE PURPOSES ONLY
4.2.1.6 Procedure: Provide step-by-step instructions for the procedure. Refer to
other SOPs or literature when appropriate. Write the procedure section at
a level that would allow any reader, who is versed in the general
knowledge to which the SOP pertains, to be able to perform the
procedure and obtain the desired results.
4.2.1.7 Definitions and Abbreviations (Optional): Define any terms used in
the procedure which may be unfamiliar to the user. Keep in mind that
SOPs are also training tools and this section can be explanatory or
educational.
4.2.1.8 Safety Considerations (Optional): If it is appropriate, provide examples
of any safety considerations for the SOP. There are some SOPs that
require approval and signature from the Environmental Health and Safety
Program (EHSP).
4.2.1.9 References and Related Documents (Optional): List any references
such as Code of Federal Regulations, Batch Production Records, or
publications applicable to the document. List referenced SOPs, MPRs,
etc., as applicable to the SOP. Do not list an SOP unless it is mentioned
in the body of the document. Do not include the revision number of the
SOP. Add regulatory references as necessary and the name of
equipment manuals when appropriate.
4.2.1.10 Attachments: Attach tables, examples of forms, technical literature,
diagrams, or any other information which will assist the user in following
the SOP. The use of flow charts and diagrams is encouraged.
List flow charts and diagrams first then forms associated with the
SOP.
List the word Attachment and the number in BOLD, followed by the
title of the attachment.
4.2.2 Other sections of the SOP shall be tailored to suit the purpose of the SOP and to
ultimately provide a clear, concise document. The following are some examples of
additional sections.
Acronyms
Calculations (calculations must include units)
Calibration
Disposition
Documentation
Formats
Safety Data Sheets
Quality Control
Reagents
Required Equipment (with Master Equipment File number)
BDP Part Numbers
Required Materials and Documentation
This procedure is made available through federal funds from the National Cancer Institute, NIH, under contract .
Page 7 of 12
FNLCR, BDP
SOP Number: 21400
Revision Number: 05
EffectiveDate: SEP 13 2018
UNCONTROLLED COPY FOR TRAINING AND REFERENCE PURPOSES ONLY
4.3 SOP Identification
4.3.1 Assigning SOP Numbers
4.3.1.1 BQA provides SOP number assignments in accordance with the
categories of procedures as shown in Attachment 2.
4.3.1.2 BQA maintains the SOP/MEF Database for an up-to-date list of BDP
SOPs with the effective dates and maintains master SOP files by
document number.
5.0
Definitions
5.1 Standard Operating Procedure (SOP) A document that describes a policy, system
and/or routine operation (such as a technical procedure, the use, cleaning and
maintenance of equipment, validation and calibration procedures, or document
preparation).
6.0
References and Related Documents
6.1 SOP 21418 Control and Request of Documents/Records
6.2 SOP 21419 Origination, Modification, and Approval of Documents
6.3 21 CFR 58.81(a): GLPTesting Facilities Operation
A testing facility shall have standard operating procedures in writing setting forth nonclinical
laboratory study methods that management is satisfied are adequate to ensure the quality
and integrity of the data generated during a study.
6.4 21 CFR 211.100(a): Drugs Written Procedures
There shall be written procedures for production and process control designed to assure
that the drug products have the identity, strength, quality, and purity they purport or are
represented to possess. These written procedures, including any changes, shall be
drafted, reviewed, and approved by the appropriate organizational units and reviewed and
approved by the quality control unit.
7.0 Attachments
7.1 Attachment 1 SOP Template
7.2 Attachment 2 SOP Numbering System
This procedure is made available through federal funds from the National Cancer Institute, NIH, under contract .
Page 8 of 12
FNLCR, BDP
SOP Number: 21400
Revision Number: 05
EffectiveDate: SEP 13 2018
UNCONTROLLED COPY FOR TRAINING AND REFERENCE PURPOSES ONLY
B
Frederick National Laboratory for
Cancer
Research
,
Frederick,
MD
I I I
D
Biopham1aceutical Development Program
Title:
SOP Numbe r:
Supersedes : Revision
Attachment 1
SOP Template
Standard Operating Procedure
Revision Number :
Eff ecti ve Date:
Page 1 of 2
Origi nato r/Date:
Approval/Date :
Approval/Date :
Table of Contents
1.0 Purpose
2.0 Scope
3.0
Authority and Responsibility
4.0 Procedure
5.0
References and Related Documents
6.0
Attachments
1.0 Purpose
2.0 Scope
3.0
Author ity and Respons ibility
4.0 Procedure
5.0
References and Related Documents
6.0 Attachments
This procedureis made available through federal funds from the National cancer Institute, NIH, undercontract
This procedure is made available throughfederal fundsfrom the National Cancer Institute, NIH, under contract
Page 9 of 12
FNLCR, BDP
SOP Number: 21400
Revision Number: 05
EffectiveDate: SEP 13 2018
UNCONTROLLED COPY FOR TRAINING AND REFERENCE PURPOSES ONLY
Attachment 1 (Continued)
SOP Templates
FNLCR, BOP
SOP Numbe:r
Titl e:
RevisionNumber: EffectiveDate:
Attachment 1
Page 2 of2
This procedure is made available through fe<leral funds from the National cancer Institute, NIH, under contract
This procedure is made available throughfederal funds from the National Cancer Institute, NIH, under contract
Page 10 of 12
FNLCR, BDP
SOP Number: 21400
Revision Number: 05
EffectiveDate: SEP 13 2018
UNCONTROLLED COPY FOR TRAINING AND REFERENCE PURPOSES ONLY
Attachment 2
SOP Numbering System
Number Series
Department
I
Category
7000- 9999
BDP Policies
10000
Manufa
cturina
Oper ations
10000
Adm
in istration
and Manaaement
10100
In f orma
t ion
Techno
loav
10200
Data Management
10300
B u ild ing and Facility
10400
Tra in ing
10500
Ne twork
10600
Te lecommun
ica ti ons
10700
Ha rdware
and Software
10800
Pu rchas ing and Receiving
10900
In ternal
D istr ibut ion
10950
Inven
torv
Cont
ro l
10970
M isce
llaneous
11000
F ac ilities
and Eauioment
11000
Adm
in istration
and Manaaement
11100
Fac ilities
11200-11800
Ava ilab le
11900
M isce
llaneous
12000
L ate Pr oc ess
S c ien c es
-
Fermentation
12000
Adm
in istration
and Manaaement
12100-12299
Gene ral
P r ocedures
12300-12800
Ava ilab le
12900
M isce
llaneous
13000
Early Process Sciences
-
Cell Culture
13100
Adm
in i stration
and Management
13200
Gene
ral
P rocedures
13300-13800
Ava ilab le
13900
M isce
llaneous
14000
L ate Pr oc ess
S c ien c es
-
Purifi
c ati o n
14000
Adm
in istration
and Management
14100
Gene
r al
P r ocedures
14200-14800
Ava ilab le
14900
M isce
llaneous
15000
L ate Pr oc ess
S c ien c es
-
Fill /Finish
15000
Adm
in istration
and Manaaement
15100
Gene
r al
P r ocedures
15200-15800
Ava ilab le
15900
M isce
llaneous
Th is procedure is made available throughfederal fundsfrom the National Cancer Institute, NIH, under contract
Page 11 of 12
FNLCR, BDP
SOP Number: 21400
Revision Number: 05
EffectiveDate: SEP 13 2018
UNCONTROLLED COPY FOR TRAINING AND REFERENCE PURPOSES ONLY
Att achment 2 (Continued)
SOP Numbering System
Number Series
Department
I
Category
16000
PA Develooment - Analvt ical
16000
Adm in istrat ion and Manaaement
16100
Ana lvtical Test Methods
16200
Produc
t ion
and Process Methods
16300-16800
Ava ilable
16900
M iscellaneous
17000
E a rly Pr oc ess
Sc ien c es
-
Vir ology
17000
Adm in istrat ion and Manaaement
17100
Genera
l P rocedures
17200-17800
Ava ilable
17900
M iscella n eous
18000
Open
19000
L ate Pro c ess
S c ien c es
-
Suoo
o rt
19000
Adm in istrat ion and Manaaement
19100
G lass w a r e and Hardware Cleanina, Preparation, etc.
19200
Eau
ipment
Lub
rican ts , etc .
19300
San
itation
D isin fectan
ts , etc .
19400-19500
Manu factur ing Suooort
19600-19800
Ava ilable
19900
M iscellaneous
20000
M aterials Manaaement and lnventorv Control
20000
Adm in istrat ion and Manaaement
20100
Rece
iv ina
20200
Sh ipp ing
20300
Inven
tory
Cont
rol /Warehouse
20400
Returns , Recalls
, etc.
20500-20800
Ava ilable
20900
M iscellaneous
21000
Qualitv Assurance
21000
Adm in istrat ion and Management
21100
Interna
l a n d
E xterna
l A u d iting , Vendor Qualification
21200
Change Control
21300
Dev iat ions and Non-conformance
21400
Documentation and Labelina
21500
Qual itv E n aineerina, Validation, Calibration
21600
T rain ina
21700
Au d it ing
21800
Ava ilable
21900
M iscellaneous
This procedure is madeavailable through federal funds from the National Cancer Institute, NIH, under contract
Page 12 of 12
FNLCR, BDP
SOP Number: 21400
Revision Number: 05
EffectiveDate: SEP 13 2018
UNCONTROLLED COPY FOR TRAINING AND REFERENCE PURPOSES ONLY
Attachment 2 (Continued)
SOP Numbering System
Number Series
Department
I
Category
22000
Pro c ess Analvti
c s
22000
Administration and Manaaement
22100
Assavs
22200
Assays
22300
Environmental Monitoring
22400
Out-of-Specifications
22500
Stability Studies
22600
Component Controls
22700
QC Tests and Standards
22800
Packaaina
22900
Miscellaneous
23000
Pro c ess Analyti
c s
-
Mi c robi o loav
23100
Assays
23200 to 23900
Available
24000
Reaulat o rv Affairs
24000
Administration and Manaaement
24100
Internal Policies and Procedures
24200
Compliance with Federal, State and Local Regulations
24300
Interactions with FDA and Other Regulatory Agencies
24400
Regulatory Documents
24500-24800
Available
24900
Miscellaneous
25000
Earlv Process Sciences
-
Research and Develooment
25000
Administration and Management
25100
General Procedures
25200-25800
Available
25900
Miscellaneous
26000
Safetv
26000
Safety Committee and Related
26100
General Safety
26200
Chemical Safety
26300
Biological and Recombinant Safety
26400
Radiological Safety
26500
Environmental Safety
26600-26800
Available
26900
Miscellaneous
27000 -99000
Av ailable
This procedure is made available through federal funds from the National Cancer Institute, NIH, undercontract